Navigation Links
SuperScript II RNase H- Reverse Transcriptase from Invitrogen

ProductsSuperScript II RNase H- Reverse Transcriptase from Invitrogen
Company Invitrogen
Item SuperScript II RNase H- Reverse Transcriptase
Description SuperScript™ II RNase H- Reverse Transcriptase (RT) is an improved version of the SuperScript™ RNase H- RT. It is a DNA polymerase that synthesizes a complementary DNA strand from single-stranded RNA DNA or an RNA:DNA hybrid. This enzyme is genetically engineered by the introduction of point mutations rather than a deletion in the RNase H active center. Like SuperScript™ RT SuperScript™ II RT has 106- to 107-fold reduced RNase H activity. Unlike SuperScript™ RT however the selective mutations within the RNase H domain maintain full polymerase activity. This structural modification eliminates degradation of RNA molecules during first-strand cDNA synthesis and gives SuperScript™ II RT superior performance characteristics.
Info InvitrogenInvitrogen
Invitrogen Corporation
1600 Faraday Ave.
Carlsbad, CA 92008

Call Invitrogen to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-521-4270
Customer Service: 800-955-6288
Tech Support: 800-955-6288 ext. 2
Fax Number: 760-603-7229
Web Site:
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. SuperScript II RNase H- Reverse Transcriptase from Invitrogen
2. SuperScript III RNase H- Reverse Transcriptase from Invitrogen
3. SuperScript Plasmid System and MAX Efficiency DH10BCompetent Cells from Invitrogen
4. SuperScript Indirect cDNA Labeling System from Invitrogen
5. GeneRacer Kit with SuperScript II RT and Zero Blunt TOPO PCR Cloning kit for Sequencing from Invitrogen
6. DNase I (RNase-free) (2 U/l) from Ambion
7. QIAGEN RNase Inhibitor (7500 U) from QIAGEN
8. ShortCut RNase III from New England Biolabs
9. RNase H from Roche Applied Science
10. RNase-Free Dnase from BD Biosciences Pharmingen
11. RQ1 RNase-Free DNase from Promega
... microRNA expression profiling and built on ... on-chip synthesis platform. These microarrays are ... microRNA Expression Profiling Service. ... Microarray contains all known mammal microRNAs ...
... Proteolytic degradation is critical to ... short-lived and regulatory proteins as important ... cellular metabolism, heat shock and stress ... surface receptors and ion channels, cell ...
... Human Serum • Human serum is obtained ... to be negative by a test for ... to Human Immunodeficiency Virus (Anti-HIV 1/2), Hepatitis ... B Surface Antigen (HbsAg) and Non-reactive by ...
... for whole-blood clinical diagnostic work in hospitals ... this analyzer makes precise glucose measurements of ... lactate measurements of whole blood, plasma, or ... allows you to have glucose results expressed ...
Biology Products:
(Date:11/16/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced expansion of its TDDI product portfolio with ... and display driver integration (TDDI) solutions designed to ... TDDI products add to the previously-announced TD4300 ... resolution), and TD4322 (FHD resolution) solutions. All four ...
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and ... early in their initial angel funding process. Now, they are paying it forward ... make early stage investments in the microbiome space. In this, they join ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... Conference in New York on Wednesday, December ... Helen Torley , president and CEO, will provide a corporate overview. ... New York at 1:00 p.m. ET/10:00 a.m. PT . ... investor relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology: